Carbapenemases, bacterial enzymes that typically inactivate most of the β-lactam class of antimicrobial drugs, have emerged rapidly over the past decade ([@R1]). These resistance mechanisms are often accompanied by other resistance alleles, and together they can confer extensive drug resistance, leaving minimal treatment options ([@R2]). The New Delhi metallo-β-lactamase variant 1 (NDM-1), a chimera formed by the fusion of 2 resistance genes, is unique among the carbapenemases ([@R3]). Since its description in 2009, NDM-1 has spread rapidly to many countries worldwide and appears to be endemic in South Asia ([@R1],[@R4],[@R5]). A study of the environment in New Delhi, India, showed that ≈30% of surface waters and sewage was contaminated with NDM-1; the enzyme was also detected in drinking water ([@R6]). In addition, high rates of NDM-1 gut carriage have been found in the community and in hospitals in Pakistan ([@R7]). High rates of gut carriage can lead to contamination of drinking water and food through inadequate sewage treatment. Furthermore, gut carriage of NDM-1--encoding *Escherichia coli* can lead to common community-acquired infections (e.g., urinary tract infections), which often require hospitalization ([@R8]) and enable resistance mechanisms to move between community and hospital sectors. Indirect studies in 2009 and 2010 showed that NDM-1 was not present in the Bangladesh environment ([@R9],[@R10]). To determine whether NDM-1 is now present in Bangladesh, we surveyed the environmental waters of Dhaka.

The Study
=========

During October 19--27, 2012, we collected environmental water/sewage samples from 7 regions (58 sites) in Dhaka, Bangladesh ([Figure 1](#F1){ref-type="fig"}). Control samples were from the United Kingdom. Each sample was investigated for bacterial growth on UTI brilliance agar plates (Thermo Fischer Scientific, Basingstoke, UK) containing vancomycin (30 mg/L) plus meropenem (0.5 mg/L). The species of individual colonies of different colors and morphologies were determined by using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Bacteria were genetically characterized by *bla*~NDM-~specific PCR. Genetic location of the *bla*~NDM-1~ gene was determined by probing S1 nuclease pulsed-field gels. A subset of isolates of each species was further investigated for MICs of relevant antimicrobial drugs. All *E. coli* isolates were genotyped to determine multilocus sequence typing group; examples of each group were characterized for additional relevant resistance mechanisms. Details are provided in the [Technical Appendix](#SD1){ref-type="local-data"}.

![Diversity of New-Delhi metallo-β-lactamase variant 1--encoding species and the number found in 58 locations in 7 regions (red circles on map) of Dhaka, Bangladesh, October 2012. Individual sampling sites were within 2 km of each sampling region, and the number of sites varied from 6 to 12 per region. Pie charts indicate the proportions of different *bla*~NDM-1~--positive bacteria isolated in each region; colors indicate specific species. The diameter of each pie chart is directly proportional to the number of *bla*~NDM-1~--positive isolates collected in each region; actual numbers are shown in parentheses after the region name. Numbers within pie charts indicate the percentage of sites in each region in which the individual positive *bla*~NDM-1~--positive species were found. *bla*~NDM-1~ was detected in samples from all 7 regions and from 36 (62%) of the 58 sampling sites.](14-1578-F1){#F1}

The carbapenemase and extended-spectrum β-lactamase genes *bla*~NDM-1~ and *bla*~CTX-M-15~ were detected by PCR in 36 (62%) and 41 (71%), respectively, of the 58 water samples. Both genes were found at all 7 sample region sites in Dhaka. Gene *bla*~CTX-M-15~, but not *bla*~NDM-1~, was detected in sewage samples from the United Kingdom; neither was detected in UK water samples from the River Thames.

We identified 226 gram-negative NDM-1--producing isolates to the species level ([Figure 1](#F1){ref-type="fig"}; [Technical Appendix](#SD1){ref-type="local-data"} Table 1); 15 isolates harboring *bla*~NDM-1~ could not be identified and were not investigated further. The most widely disseminated bacteria in samples from Dhaka were pseudomonads (6/7 regions) and *Klebsiella pneumoniae* (4/7 regions). Nine different species of *Pseudomonas* spp. and 5 *Acinetobacter* spp., mostly belonging to nonpathogenic strains, were among the nonfermentative bacteria ([Technical Appendix](#SD1){ref-type="local-data"} Table 1). Carbapenem resistance in the *Pseudomonas* spp. isolates was unstable; all strains lost the *bla*~NDM-1~ gene after 2 days' growth or when frozen for storage.

With the exception of 4 isolates, all bacterial isolates contained the original *bla*~NDM-1~ allele; 3 *E. coli* sequence type (ST) 101 isolates carried the *bla*~NDM-3~ variant, and 1 ST648 isolate carried the *bla*~NDM-4~ variant ([Technical Appendix](#SD1){ref-type="local-data"} Table 2). S1 nuclease pulsed-field gel electrophoresis combined with *bla*~NDM-1~ probes detected *bla*~NDM-1~ on plasmids of limited size diversity in *E. coli* (ST101, 160 kb; ST405, 100 kb; ST648, 150 kb); however, other species included *bla*~NDM-1~--positive plasmids in a wide diversity of sizes (30 kb--450 kb); some of these species had multiple positive plasmids, and *bla*~NDM-1~ was also found on the chromosome ([Technical Appendix](#SD1){ref-type="local-data"} Table 1 and [Figure 1](#F1){ref-type="fig"}).

The *E. coli* isolates were further analyzed by PCR to identify additional resistance mechanisms often associated with *bla*~NDM-1~ ([Table](#T1){ref-type="table"}). *bla*~CTX-M-15~ and 16s ribosomal methylase genes (*armA* or *rmtB*) were associated with most *E. coli* strains, which explains the extensively drug-resistant phenotype of the *E. coli* isolates ([Technical Appendix](#SD1){ref-type="local-data"} Table 3). Plasmids of plasmid incompatibility groups *inc*FII (ST101, ST405, ST648) and *inc*X (ST405, ST648) were also closely associated with *E. coli* strains ([Table](#T1){ref-type="table"}). *E. coli* harboring *bla*~NDM-1~ were isolated from 10 sampling sites ([Figure 1](#F1){ref-type="fig"}; [Technical Appendix](#SD1){ref-type="local-data"} Table 1). *The E. coli* isolates belonged to 3 different multilocus sequence typing groups: ST101 (phylogroup B1, 20/53 samples); ST405 (phylogroup D, 5/53 samples); and ST648 (phylogroup D, 28/53 samples) ([Technical Appendix](#SD1){ref-type="local-data"} Table 2). ST101, which was found in samples from 6 (10.3%) of the 58 sites, was the most prevalent NDM-1--encoding *E. coli* genotype. ST648 represented an intermediate prevalence (5/58 \[8.6%\] sites), and ST405 was the least prevalent (1/58 \[1.7%\] sites) ([Technical Appendix](#SD1){ref-type="local-data"} Tables 1, 2).

###### Resistance genes and plasmid profiles for a subset of *Escherichia coli* strains in a study of extensively drug-resistant New Delhi metallo-β-lactamase--encoding bacteria in the environment, Dhaka, Bangladesh, October 2012\*

  ***E. coli* strain, ST**   **Resistance genes**                                                     
  -------------------------- ---------------------- ------- -------- -------------- ---- ---- --- --- ---
  **18, ST101**              \+                     NDM-3   *rmtB*   −              −    \+   −   −   −
  **24, ST101**              \+                     NDM-3   *rmtB*   −              −    \+   −   −   −
  **25, ST101**              \+                     \+      *rmtB*   −              −    \+   −   −   −
  **28, ST101**              \+                     NDM-3   *rmtB*   −              −    \+   −   −   −
  **221, ST101**             \+                     NDM-1   *rmtB*   −              −    \+   −   −   −
  **34, ST648**              \+                     \+      *armA*   *cmy*, *dha*   \+   \+   −   −   −
  **192, ST648**             \+                     NDM-4   *armA*   *cmy*, *dha*   \+   \+   −   −   −
  **346, ST648**             \+                     \+      *armA*   *cmy*, *dha*   \+   \+   −   −   −
  **43, ST405**              \+                     NDM-1   *armA*   *cmy*, *dha*   \+   \+   −   −   −
  **54, ST405**              \+                     NDM-1   *armA*   *cmy*, *dha*   \+   \+   −   −   −

**\**armA* and *rmtB*, aminoglycoside methylase genes; CTX-M-15, *cmy*, and *dha,* β-lactamases; *inc*, plasmid incompatibility group; NDM, New-Delhi metallo-β-lactamase; ST, sequence type; −, negative; +, positive.**

Conclusions
===========

Our findings indicate that NDM-1 is widespread in the Dhaka environment. We detected 241 NDM-1--encoding bacterial isolates; they were found in all 7 sampled regions and at 36 (62%) of the 58 sampling sites. This high level of environmental *bla*~NDM-1~ contamination is of concern, especially because drinking water in Bangladesh usually carries high levels of sewage-derived bacteria ([@R11]). It is therefore likely that *bla*~NDM-1~ carriage rates will rise rapidly. Future environmental studies could provide indicators of epidemics of emerging resistant bacteria before they are realized in hospitals.

Despite the widespread presence of NDM-1 in Dhaka, it appears that this carbapenemase has recently emerged in the Bangladesh environment. Studies in northern Bangladesh did not find NDM-1 in wild ducks and poultry in 2009 ([@R9]) or in crow and gull feces in 2010 ([@R10]). Similarly, NDM-1 was not detected in drinking water in Dhaka during 2008--2009 ([@R11]) even though all samples had high levels of fecal and *bla*~CTX-M-15~ contamination. Furthermore, a study of 1,879 clinical *E. coli* and *Shigella* spp. isolates collected during 2009--2010 in Bangladesh did not detect *bla*~NDM-1~ ([@R12]). The first known clinical isolates date from 2008 ([@R12]), and the first evidence of human gut carriage of *bla*~NDM-1~ was found in samples collected in Dhaka ([@R13]) a month before our study.

Because *E. coli* is the leading cause of human urinary tract infections, bloodstream infections, and neonatal meningitis, the ability of NDM-1 to give this bacterium clinical resistance to carbapenems is of concern ([@R14]). *E. coli* is also universally carried in the human gut. Therefore, we focused on this species because it is likely to be the greatest threat to human health. *E. coli* encoding NDM-1 were found in 3 of the 7 sampled regions, and genotyping showed they belonged to only 3 STs: ST648, ST101, and ST405. These same 3 *E. coli* genotypes are responsible for 80% of clinical NDM-1--encoding *E. coli* isolates in the United Kingdom ([@R15]). Furthermore, ST101 is the most common *E. coli* genotype in the Bangladesh environment (10.3% prevalence) and in clinical isolates from the United Kingdom (50%). Results of a literature search for NDM-1--encoding *E. coli* belonging to ST101 showed that this genotype has been detected in 15 nations ([Figure 2](#F2){ref-type="fig"}). Thus, *E. coli* ST101 appears to be a successful global genotype that is often associated with NDM-1. This association with a single global genotype is analogous to the association between *E. coli* ST131 and the cephalosporinase CTX-M-15. Because of the critical nature of extensively drug-resistant bacteria, we are investigating the underlying factors responsible for the success of these particular antimicrobial drug--resistant strains.

![Sites where New-Delhi metallo-β-lactamase variant 1 (NDM-1)--encoding *Escherichia coli* sequence type (ST) 101 isolates have been detected worldwide. Stars indicate countries where NDM-encoding *E. coli* ST101 has been detected: Australia, Bangladesh, Belgium, Bulgaria, China, Canada, Denmark, France, Germany, India, Korea, New Zealand, Pakistan, the United Kingdom, and the United States.](14-1578-F2){#F2}
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**Technical Appendix.** Methods and Results for a study of extensively drug-resistant New Delhi metallo-β-lactamase--encoding bacteria in the environment, Dhaka, Bangladesh, October 2012; genomic location of *bla*~NDM-1~ in environmental bacteria from Dhaka; list of isolates; and phylogenetic analysis of NDM-positive *Escherichia coli* from the environment
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